Embecta Corp Stock Today
| EMBC Stock | USD 13.63 0.48 3.65% |
PerformanceVery Weak
| Odds Of DistressLow
|
Embecta Corp is trading at 13.63 as of the 17th of March 2025, a 3.65% increase since the beginning of the trading day. The stock's open price was 13.15. Embecta Corp has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Note, on April 26, 2022, Representative Tom Cole of US Congress acquired under $15k worth of Embecta Corp's common stock.
Business Domain Health Care Equipment & Services | IPO Date 1st of April 2022 | Category Healthcare | Classification Health Care |
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 58.13 M outstanding shares of which 1.65 M shares are currently shorted by private and institutional investors with about 4.47 trading days to cover. More on Embecta Corp
Moving against Embecta Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Embecta Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Devdatt Kurdikar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsEmbecta Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Embecta Corp's financial leverage. It provides some insight into what part of Embecta Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embecta Corp (EMBC) is traded on NASDAQ Exchange in USA. It is located in 300 Kimball Drive, Parsippany, NJ, United States, 07054 and employs 2,100 people. Embecta Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 764.47 M. Embecta Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 58.13 M outstanding shares of which 1.65 M shares are currently shorted by private and institutional investors with about 4.47 trading days to cover.
Embecta Corp currently holds about 292.3 M in cash with 35.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.05.
Check Embecta Corp Probability Of Bankruptcy
Ownership AllocationEmbecta Corp holds a total of 58.13 Million outstanding shares. The majority of Embecta Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Embecta Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Embecta Corp. Please pay attention to any change in the institutional holdings of Embecta Corp as this could imply that something significant has changed or is about to change at the company. On April 26, 2022, Representative Tom Cole of US Congress acquired under $15k worth of Embecta Corp's common stock.
Check Embecta Ownership Details
Embecta Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 986.5 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 888.9 K | |
| Ubs Group Ag | 2024-12-31 | 802.9 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 788.4 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 782.2 K | |
| William Blair Investment Management, Llc | 2024-12-31 | 739.5 K | |
| Northern Trust Corp | 2024-12-31 | 701 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 685.5 K | |
| Balyasny Asset Management Llc | 2024-12-31 | 641 K | |
| Blackrock Inc | 2024-12-31 | 9.3 M | |
| Vanguard Group Inc | 2024-12-31 | 7 M |
Embecta Corp Historical Income Statement
Embecta Stock Against Markets
Embecta Corp Corporate Management
| Pravesh Khandelwal | VP Relations | Profile | |
| Anthony Roth | Chief VP | Profile | |
| Jeffrey Mann | General VP | Profile | |
| Shaun Curtis | Senior Chain | Profile | |
| Ginny Blocki | Senior Management | Profile | |
| Ajay Kumar | VP Officer | Profile | |
| Jean Casner | Senior Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 0.6 | Earnings Share 0.99 | Revenue Per Share | Quarterly Revenue Growth (0.06) |
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.